Is viral hepatitis the same as hepatitis B?

May 24, 2022 Source: Cainiu Health
Dr. Jiang Weimin
Introduction
Viral hepatitis is not synonymous with hepatitis B. The distinction lies in the fact that viral hepatitis refers to a group of infectious diseases primarily characterized by liver damage, caused by various distinct hepatitis viruses. To date, at least five types of hepatitis viruses have been identified: hepatitis A, B, C, D, and E viruses. Hepatitis B is merely one subtype of viral hepatitis. For hepatitis A and E, prevention primarily focuses on interrupting the fecal-oral transmission route.

Humans are universally susceptible to all types of viral hepatitis, and individuals of any age can be affected. Therefore, effective prevention is essential. But is viral hepatitis the same as hepatitis B?

Is viral hepatitis the same as hepatitis B?

No, viral hepatitis is not synonymous with hepatitis B. Viral hepatitis refers to a group of infectious diseases primarily affecting the liver and caused by various distinct hepatitis viruses. To date, at least five types of hepatitis viruses have been identified: hepatitis A, B, C, D, and E viruses. Hepatitis B is merely one subtype within this broader category of viral hepatitis. In daily life, many people mistakenly equate hepatitis B infection with being a hepatitis B carrier—and consequently avoid both groups indiscriminately. Although both individuals test positive for hepatitis B surface antigen (HBsAg), they differ significantly in clinical presentation and management.

A patient with hepatitis B is an active carrier of the hepatitis B virus who exhibits clinical symptoms and abnormal liver function test results. In contrast, a hepatitis B carrier harbors the virus but remains asymptomatic, with normal liver function. Thus, antiviral therapy is generally unnecessary for carriers—except for certain high-risk occupational groups such as childcare workers and military personnel, who may require treatment.

Given universal human susceptibility to all forms of viral hepatitis across all age groups, comprehensive prevention and control measures are imperative. For newly emerging hepatitis viruses and hepatitis E, interrupting the fecal-oral transmission route is the primary preventive strategy. For hepatitis B and hepatitis D, vaccination against hepatitis B is the cornerstone of prevention. For hepatitis C, controlling parenteral transmission routes—particularly bloodborne exposure—is paramount. Early detection, early diagnosis, early isolation, early reporting, early treatment, and prompt management of outbreak sites are critical to preventing epidemics and improving therapeutic outcomes. Protecting susceptible populations and reducing disease incidence remain top priorities. We hope this article has been helpful to you. Wishing you a joyful life and good health!